Sign up for our Oncology Central weekly news round-up

TruSight™ Oncology 500: a comprehensive tumor profiling assay

Written by Illumina

TruSight™ Oncology 500 is a comprehensive tumor profiling assay designed to identify known and emerging tumor biomarkers —including small variants, splice variants, and fusions. Importantly, TruSight Oncology 500 can measure tumor mutational burden (TMB) and microsatellite instability (MSI), features that are potentially key biomarkers for emerging immunotherapies.

Interested in finding out more? Click here

For Research Use Only.  Not for use in diagnostic procedures.

QB# 7038